Concepedia

Masood Bhatti

MB

Statistics

Publications

5

Citations

142

H-Index

5

Active since

2011

Affiliations

Nuvisan (Germany)(Current)

Worldwide Clinical Trials (United States)

MPI Research (United States)

Pharmaceutical Product Development (United States)

Celerion (United States)

Masood Bhatti is an author at Nuvisan (Germany) specializing in pharmacy, biopharmaceutics, and pharmaceutical analysis.

Publications per year

2011–2012

5

Publications

5

Recommendations on The Interpretation of The New European Medicines Agency Guideline on Bioanalytical Method Validation By Global Cro Council For Bioanalysis (Gcc)

Mark Boterman, Mira Doig, Massimo Breda et al. · Bioanalysis · 2012 · 44 citations

, , +15

Recommendations on Bioanalytical Method Stability Implications of Co-Administered And Co-Formulated Drugs By Global Cro Council For Bioanalysis (Gcc)

Steve Lowes, Mark Boterman, Mira Doig et al. · Bioanalysis · 2012 · 32 citations

, , +16

Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop summary report

Mei‐Ling Chen, Vinod P. Shah, Daan J.A. Crommelin et al. · European Journal of Pharmaceutical Sciences · 2011 · 26 citations

, , +15

Conference Report: 4Th Global Cro Council For Bioanalysis: Coadministered Drugs Stability, Ema/Us Fda Guidelines, 483S And Carryover

Steve Lowes, Jim Jersey, Ronald E. Shoup et al. · Bioanalysis · 2012 · 23 citations

, , +12

Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop Summary Report

Mei‐Ling Chen, Vinod P. Shah, Daan J.A. Crommelin et al. · The AAPS Journal · 2011 · 17 citations

, , +15

1–5 of 5